{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T03:32:27Z","timestamp":1788838347291,"version":"build-2803163510"},"publisher-location":"Cham","reference-count":70,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783031319778","type":"print"},{"value":"9783031319785","type":"electronic"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-3-031-31978-5_29","type":"book-chapter","created":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T21:02:35Z","timestamp":1690837355000},"page":"281-287","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Lipid Profiling in Alzheimer\u2019s Disease"],"prefix":"10.1007","author":[{"given":"Cristina","family":"Zivko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram","family":"Sagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariadni","family":"Xydia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Mahairaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,1]]},"reference":[{"key":"29_CR1","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1016\/j.molcel.2021.08.027","volume":"81","author":"H Yoon","year":"2021","unstructured":"Yoon, H., Shaw, J. L., Haigis, M. C. & Greka, A. Lipid metabolism in sickness and in health: Emerging regulators of lipotoxicity. Mol. Cell 81, 3708\u20133730 (2021).","journal-title":"Mol. Cell"},{"key":"29_CR2","first-page":"637","volume":"1811","author":"E Fahy","year":"2011","unstructured":"Fahy, E., Cotter, D., Sud, M. & Subramaniam, S. Lipid classification, structures and tools. Biochim. Biophys. Acta BBA \u2013 Mol. Cell Biol. Lipids 1811, 637\u2013647 (2011).","journal-title":"Biochim. Biophys. Acta BBA \u2013 Mol. Cell Biol. Lipids"},{"key":"29_CR3","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2174\/0929867324666171003121127","volume":"26","author":"A Mika","year":"2019","unstructured":"Mika, A., Sledzinski, T. & Stepnowski, P. Current Progress of Lipid Analysis in Metabolic Diseases by Mass Spectrometry Methods. Curr. Med. Chem. 26, 60\u2013103 (2019).","journal-title":"Curr. Med. Chem."},{"key":"29_CR4","doi-asserted-by":"crossref","first-page":"10492","DOI":"10.3390\/ijms150610492","volume":"15","author":"L Li","year":"2014","unstructured":"Li, L. et al. Mass spectrometry methodology in lipid analysis. Int. J. Mol. Sci. 15, 10492\u201310507 (2014).","journal-title":"Int. J. Mol. Sci."},{"key":"29_CR5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.15280\/jlm.2014.4.1.17","volume":"4","author":"Z Wu","year":"2014","unstructured":"Wu, Z., Shon, J. C. & Liu, K.-H. Mass Spectrometry-based Lipidomics and Its Application to Biomedical Research. J. Lifestyle Med. 4, 17\u201333 (2014).","journal-title":"J. Lifestyle Med."},{"key":"29_CR6","doi-asserted-by":"crossref","first-page":"eaaw2964","DOI":"10.1126\/scisignal.aaw2964","volume":"12","author":"VB O\u2019Donnell","year":"2019","unstructured":"O\u2019Donnell, V. B., Dennis, E. A., Wakelam, M. J. O. & Subramaniam, S. LIPID MAPS: Serving the next generation of lipid researchers with tools, resources, data, and training. Sci. Signal. 12, eaaw2964 (2019).","journal-title":"Sci. Signal."},{"key":"29_CR7","doi-asserted-by":"crossref","unstructured":"Naud\u00ed, A. et al. Chapter Five \u2013 Lipidomics of Human Brain Aging and Alzheimer\u2019s Disease Pathology. in International Review of Neurobiology (ed. Hurley, M. J.) vol. 122 133\u2013189 (Academic Press, 2015).","DOI":"10.1016\/bs.irn.2015.05.008"},{"key":"29_CR8","doi-asserted-by":"crossref","unstructured":"Bruce, K. D., Zsombok, A. & Eckel, R. H. Lipid Processing in the Brain: A Key Regulator of Systemic Metabolism. Front. Endocrinol. 8, (2017).","DOI":"10.3389\/fendo.2017.00060"},{"key":"29_CR9","first-page":"347","volume":"26","author":"D Eratne","year":"2018","unstructured":"Eratne, D. et al. Alzheimer\u2019s disease: clinical update on epidemiology, pathophysiology and diagnosis. Australas. Psychiatry Bull. R. Aust. N. Z. Coll. Psychiatr. 26, 347\u2013357 (2018).","journal-title":"Australas. Psychiatry Bull. R. Aust. N. Z. Coll. Psychiatr."},{"key":"29_CR10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ene.13439","volume":"25","author":"CA Lane","year":"2018","unstructured":"Lane, C. A., Hardy, J. & Schott, J. M. Alzheimer\u2019s disease. Eur. J. Neurol. 25, 59\u201370 (2018).","journal-title":"Eur. J. Neurol."},{"key":"29_CR11","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens, P. et al. Alzheimer\u2019s disease. Lancet Lond. Engl. 397, 1577\u20131590 (2021).","journal-title":"Lancet Lond. Engl"},{"key":"29_CR12","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1017\/S135561771700100X","volume":"23","author":"MW Bondi","year":"2017","unstructured":"Bondi, M. W., Edmonds, E. C. & Salmon, D. P. Alzheimer\u2019s Disease: Past, Present, and Future. J. Int. Neuropsychol. Soc. JINS 23, 818\u2013831 (2017).","journal-title":"J. Int. Neuropsychol. Soc. JINS"},{"key":"29_CR13","doi-asserted-by":"crossref","first-page":"952","DOI":"10.2174\/1567205013666160314150501","volume":"13","author":"J Dorszewska","year":"2016","unstructured":"Dorszewska, J., Prendecki, M., Oczkowska, A., Dezor, M. & Kozubski, W. Molecular Basis of Familial and Sporadic Alzheimer\u2019s Disease. Curr. Alzheimer Res. 13, 952\u2013963 (2016).","journal-title":"Curr. Alzheimer Res."},{"key":"29_CR14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.5114\/fn.2019.85929","volume":"57","author":"A Armstrong","year":"2019","unstructured":"A Armstrong, R. Risk factors for Alzheimer\u2019s disease. Folia Neuropathol. 57, 87\u2013105 (2019).","journal-title":"Folia Neuropathol."},{"key":"29_CR15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-3-030-32633-3_3","volume":"1195","author":"CG Lyketsos","year":"2020","unstructured":"Lyketsos, C. G. Treatment Development for Alzheimer\u2019s Disease: How Are We Doing? Adv. Exp. Med. Biol. 1195, 19 (2020).","journal-title":"Adv. Exp. Med. Biol."},{"key":"29_CR16","doi-asserted-by":"crossref","first-page":"180263","DOI":"10.1038\/sdata.2018.263","volume":"5","author":"DK Barupal","year":"2018","unstructured":"Barupal, D. K. et al. Generation and quality control of lipidomics data for the alzheimer\u2019s disease neuroimaging initiative cohort. Sci. Data 5, 180263 (2018).","journal-title":"Sci. Data"},{"key":"29_CR17","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3389\/fneur.2017.00719","volume":"8","author":"JM Wilkins","year":"2018","unstructured":"Wilkins, J. M. & Trushina, E. Application of Metabolomics in Alzheimer\u2019s Disease. Front. Neurol. 8, 719 (2018).","journal-title":"Front. Neurol."},{"key":"29_CR18","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nature11405","volume":"489","author":"MJ Hawrylycz","year":"2012","unstructured":"Hawrylycz, M. J. et al. An anatomically comprehensive atlas of the adult human brain transcriptome. Nature 489, 391\u2013399 (2012).","journal-title":"Nature"},{"key":"29_CR19","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.bbalip.2015.02.007","volume":"1851","author":"G Dawson","year":"2015","unstructured":"Dawson, G. Measuring brain lipids. Biochim. Biophys. Acta 1851, 1026\u20131039 (2015).","journal-title":"Biochim. Biophys. Acta"},{"key":"29_CR20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrm.2017.138","volume":"19","author":"T Harayama","year":"2018","unstructured":"Harayama, T. & Riezman, H. Understanding the diversity of membrane lipid composition. Nat. Rev. Mol. Cell Biol. 19, 281\u2013296 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"29_CR21","doi-asserted-by":"crossref","first-page":"a004697","DOI":"10.1101\/cshperspect.a004697","volume":"3","author":"K Simons","year":"2011","unstructured":"Simons, K. & Sampaio, J. L. Membrane organization and lipid rafts. Cold Spring Harb. Perspect. Biol. 3, a004697 (2011).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"29_CR22","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0022-2275(20)39619-X","volume":"6","author":"JS O\u2019Brien","year":"1965","unstructured":"O\u2019Brien, J. S. & Sampson, E. L. Lipid composition of the normal human brain: gray matter, white matter, and myelin*. J. Lipid Res. 6, 537\u2013544 (1965).","journal-title":"J. Lipid Res."},{"key":"29_CR23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0009-3084(71)90031-4","volume":"6","author":"RV Panganamala","year":"1971","unstructured":"Panganamala, R. V., Horrocks, L. A., Geer, J. C. & Cornwell, D. G. Positions of double bonds in the monounsaturated alk-1-enyl groups from the plasmalogens of human heart and brain. Chem. Phys. Lipids 6, 97\u2013102 (1971).","journal-title":"Chem. Phys. Lipids"},{"key":"29_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2014.06.002","volume":"0","author":"H-Y Kim","year":"2014","unstructured":"Kim, H.-Y., Huang, B. X. & Spector, A. A. Phosphatidylserine in the Brain: Metabolism and Function. Prog. Lipid Res. 0, 1\u201318 (2014).","journal-title":"Prog. Lipid Res."},{"key":"29_CR25","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.bbalip.2017.02.002","volume":"1862","author":"A Traynor-Kaplan","year":"2017","unstructured":"Traynor-Kaplan, A. et al. Fatty-acyl chain profiles of cellular phosphoinositides. Biochim. Biophys. Acta 1862, 513\u2013522 (2017).","journal-title":"Biochim. Biophys. Acta"},{"key":"29_CR26","doi-asserted-by":"crossref","first-page":"C876","DOI":"10.1152\/ajpcell.00342.2010","volume":"299","author":"S Grinstein","year":"2010","unstructured":"Grinstein, S. Imaging signal transduction during phagocytosis: phospholipids, surface charge, and electrostatic interactions. Am. J. Physiol.-Cell Physiol. 299, C876\u2013C881 (2010).","journal-title":"Am. J. Physiol.-Cell Physiol."},{"key":"29_CR27","doi-asserted-by":"crossref","first-page":"554","DOI":"10.5607\/en.2019.28.5.554","volume":"28","author":"U Jin","year":"2019","unstructured":"Jin, U., Park, S. J. & Park, S. M. Cholesterol Metabolism in the Brain and Its Association with Parkinson\u2019s Disease. Exp. Neurobiol. 28, 554\u2013567 (2019).","journal-title":"Exp. Neurobiol."},{"key":"29_CR28","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrm.2017.16","volume":"18","author":"E Sezgin","year":"2017","unstructured":"Sezgin, E., Levental, I., Mayor, S. & Eggeling, C. The mystery of membrane organization: composition, regulation and roles of lipid rafts. Nat. Rev. Mol. Cell Biol. 18, 361\u2013374 (2017).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"29_CR29","doi-asserted-by":"crossref","first-page":"e21643","DOI":"10.1371\/journal.pone.0021643","volume":"6","author":"X Han","year":"2011","unstructured":"Han, X. et al. Metabolomics in early Alzheimer\u2019s disease: identification of altered plasma sphingolipidome using shotgun lipidomics. PloS One 6, e21643 (2011).","journal-title":"PloS One"},{"key":"29_CR30","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1042\/BJ20110566","volume":"438","author":"L Hejazi","year":"2011","unstructured":"Hejazi, L. et al. Mass and relative elution time profiling: two-dimensional analysis of sphingolipids in Alzheimer\u2019s disease brains. Biochem. J. 438, 165\u2013175 (2011).","journal-title":"Biochem. J."},{"key":"29_CR31","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrn3820","volume":"15","author":"RP Bazinet","year":"2014","unstructured":"Bazinet, R. P. & Lay\u00e9, S. Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat. Rev. Neurosci. 15, 771\u2013785 (2014).","journal-title":"Nat. Rev. Neurosci."},{"key":"29_CR32","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.3390\/ijms21041505","volume":"21","author":"Y-C Kao","year":"2020","unstructured":"Kao, Y.-C., Ho, P.-C., Tu, Y.-K., Jou, I.-M. & Tsai, K.-J. Lipids and Alzheimer\u2019s Disease. Int. J. Mol. Sci. 21, 1505 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"29_CR33","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/MOL.0000000000000443","volume":"28","author":"H Sunshine","year":"2017","unstructured":"Sunshine, H. & Iruela-Arispe, M. L. Membrane lipids and cell signaling. Curr. Opin. Lipidol. 28, 408\u2013413 (2017).","journal-title":"Curr. Opin. Lipidol."},{"key":"29_CR34","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1385\/MN:32:1:089","volume":"32","author":"NG Bazan","year":"2005","unstructured":"Bazan, N. G. Lipid signaling in neural plasticity, brain repair, and neuroprotection. Mol. Neurobiol. 32, 89\u2013103 (2005).","journal-title":"Mol. Neurobiol."},{"issue":"Suppl 1","key":"29_CR35","first-page":"220","volume":"17","author":"D Tassoni","year":"2008","unstructured":"Tassoni, D., Kaur, G., Weisinger, R. S. & Sinclair, A. J. The role of eicosanoids in the brain. Asia Pac. J. Clin. Nutr. 17 Suppl 1, 220\u2013228 (2008).","journal-title":"Asia Pac. J. Clin. Nutr."},{"key":"29_CR36","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.plefa.2007.10.022","volume":"77","author":"PK Mukherjee","year":"2007","unstructured":"Mukherjee, P. K., Chawla, A., Loayza, M. S. & Bazan, N. G. Docosanoids are multifunctional regulators of neural cell integrity and fate: significance in aging and disease. Prostaglandins Leukot. Essent. Fatty Acids 77, 233\u2013238 (2007).","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"29_CR37","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.mam.2018.09.003","volume":"64","author":"NG Bazan","year":"2018","unstructured":"Bazan, N. G. Docosanoids and elovanoids from omega-3 fatty acids are pro-homeostatic modulators of inflammatory responses, cell damage and neuroprotection. Mol. Aspects Med. 64, 18\u201333 (2018).","journal-title":"Mol. Aspects Med."},{"key":"29_CR38","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nrn2233","volume":"8","author":"D Piomelli","year":"2007","unstructured":"Piomelli, D., Astarita, G. & Rapaka, R. A neuroscientist\u2019s guide to lipidomics. Nat. Rev. Neurosci. 8, 743\u2013754 (2007).","journal-title":"Nat. Rev. Neurosci."},{"key":"29_CR39","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/978-1-60327-029-8_21","volume":"610","author":"VA Tyurin","year":"2010","unstructured":"Tyurin, V. A. et al. Oxidative lipidomics of apoptosis: quantitative assessment of phospholipid hydroperoxides in cells and tissues. Methods Mol. Biol. Clifton NJ 610, 353\u2013374 (2010).","journal-title":"Methods Mol. Biol. Clifton NJ"},{"key":"29_CR40","doi-asserted-by":"crossref","first-page":"101082","DOI":"10.1016\/j.redox.2018.101082","volume":"23","author":"M Jov\u00e9","year":"2019","unstructured":"Jov\u00e9, M., Pradas, I., Dominguez-Gonzalez, M., Ferrer, I. & Pamplona, R. Lipids and lipoxidation in human brain aging. Mitochondrial ATP-synthase as a key lipoxidation target. Redox Biol. 23, 101082 (2019).","journal-title":"Redox Biol."},{"key":"29_CR41","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1089\/ars.2020.8238","volume":"35","author":"E Malard","year":"2021","unstructured":"Malard, E., Valable, S., Bernaudin, M., P\u00e9r\u00e8s, E. & Chatre, L. The Reactive Species Interactome in the Brain. Antioxid. Redox Signal. 35, 1176\u20131206 (2021).","journal-title":"Antioxid. Redox Signal."},{"key":"29_CR42","doi-asserted-by":"crossref","first-page":"21522","DOI":"10.1074\/jbc.M502255200","volume":"280","author":"R Pamplona","year":"2005","unstructured":"Pamplona, R. et al. Proteins in human brain cortex are modified by oxidation, glycoxidation, and lipoxidation. Effects of Alzheimer disease and identification of lipoxidation targets. J. Biol. Chem. 280, 21522\u201321530 (2005).","journal-title":"J. Biol. Chem."},{"key":"29_CR43","first-page":"168","volume":"4","author":"SAL Bennett","year":"2013","unstructured":"Bennett, S. A. L. et al. Using neurolipidomics to identify phospholipid mediators of synaptic (dys)function in Alzheimer\u2019s Disease. Front. Physiol. 4, 168 (2013).","journal-title":"Front. Physiol."},{"key":"29_CR44","doi-asserted-by":"crossref","first-page":"E314","DOI":"10.1007\/BF02854902","volume":"8","author":"RM Adibhatla","year":"2006","unstructured":"Adibhatla, R. M., Hatcher, J. F. & Dempsey, R. J. Lipids and lipidomics in brain injury and diseases. AAPS J. 8, E314-321 (2006).","journal-title":"AAPS J."},{"key":"29_CR45","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/17460441.2020.1674808","volume":"15","author":"M Cuperlovic-Culf","year":"2020","unstructured":"Cuperlovic-Culf, M. & Badhwar, A. Recent advances from metabolomics and lipidomics application in alzheimer\u2019s disease inspiring drug discovery. Expert Opin. Drug Discov. 15, 319\u2013331 (2020).","journal-title":"Expert Opin. Drug Discov."},{"key":"29_CR46","doi-asserted-by":"crossref","first-page":"101346","DOI":"10.1016\/j.arr.2021.101346","volume":"69","author":"H Hampel","year":"2021","unstructured":"Hampel, H. et al. Omics sciences for systems biology in Alzheimer\u2019s disease: State-of-the-art of the evidence. Ageing Res. Rev. 69, 101346 (2021).","journal-title":"Ageing Res. Rev."},{"key":"29_CR47","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12944-019-1044-1","volume":"18","author":"XQ Su","year":"2019","unstructured":"Su, X. Q., Wang, J. & Sinclair, A. J. Plasmalogens and Alzheimer\u2019s disease: a review. Lipids Health Dis. 18, 100 (2019).","journal-title":"Lipids Health Dis."},{"key":"29_CR48","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0531-5565(98)00014-X","volume":"33","author":"T Brosche","year":"1998","unstructured":"Brosche, T. & Platt, D. The biological significance of plasmalogens in defense against oxidative damage. Exp. Gerontol. 33, 363\u2013369 (1998).","journal-title":"Exp. Gerontol."},{"key":"29_CR49","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3233\/JAD-2010-1242","volume":"19","author":"V Mart\u00edn","year":"2010","unstructured":"Mart\u00edn, V. et al. Lipid alterations in lipid rafts from Alzheimer\u2019s disease human brain cortex. J. Alzheimers Dis. JAD 19, 489\u2013502 (2010).","journal-title":"J. Alzheimers Dis. JAD"},{"key":"29_CR50","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.neurobiolaging.2014.02.005","volume":"35","author":"N Fabelo","year":"2014","unstructured":"Fabelo, N. et al. Altered lipid composition in cortical lipid rafts occurs at early stages of sporadic Alzheimer\u2019s disease and facilitates APP\/BACE1 interactions. Neurobiol. Aging 35, 1801\u20131812 (2014).","journal-title":"Neurobiol. Aging"},{"key":"29_CR51","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/jnc.12368","volume":"127","author":"H Cheng","year":"2013","unstructured":"Cheng, H., Wang, M., Li, J.-L., Cairns, N. J. & Han, X. Specific changes of sulfatide levels in individuals with pre-clinical Alzheimer\u2019s disease: an early event in disease pathogenesis. J. Neurochem. 127, 733\u2013738 (2013).","journal-title":"J. Neurochem."},{"issue":"Suppl 1","key":"29_CR52","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1471-4159.2007.04708.x","volume":"103","author":"X Han","year":"2007","unstructured":"Han, X. Potential mechanisms contributing to sulfatide depletion at the earliest clinically recognizable stage of Alzheimer\u2019s disease: a tale of shotgun lipidomics. J. Neurochem. 103 Suppl 1, 171\u2013179 (2007).","journal-title":"J. Neurochem."},{"key":"29_CR53","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13024-021-00488-7","volume":"16","author":"S Qiu","year":"2021","unstructured":"Qiu, S. et al. Adult-onset CNS myelin sulfatide deficiency is sufficient to cause Alzheimer\u2019s disease-like neuroinflammation and cognitive impairment. Mol. Neurodegener. 16, 64 (2021).","journal-title":"Mol. Neurodegener."},{"key":"29_CR54","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1073\/pnas.0305799101","volume":"101","author":"RG Cutler","year":"2004","unstructured":"Cutler, R. G. et al. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer\u2019s disease. Proc. Natl. Acad. Sci. U. S. A. 101, 2070\u20132075 (2004).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"29_CR55","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.freeradbiomed.2012.09.027","volume":"62","author":"R Sultana","year":"2013","unstructured":"Sultana, R., Perluigi, M. & Butterfield, D. A. Lipid Peroxidation Triggers Neurodegeneration: A Redox Proteomics View into the Alzheimer Disease Brain. Free Radic. Biol. Med. 62, 157\u2013169 (2013).","journal-title":"Free Radic. Biol. Med."},{"key":"29_CR56","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/978-1-60327-029-8_25","volume":"610","author":"PI Moreira","year":"2010","unstructured":"Moreira, P. I. et al. Detection and Localization of Markers of Oxidative Stress by In Situ Methods: Application in the Study of Alzheimer Disease. Methods Mol. Biol. Clifton NJ 610, 419\u2013434 (2010).","journal-title":"Methods Mol. Biol. Clifton NJ"},{"key":"29_CR57","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/med.20073","volume":"27","author":"G Aldini","year":"2007","unstructured":"Aldini, G., Dalle-Donne, I., Facino, R. M., Milzani, A. & Carini, M. Intervention strategies to inhibit protein carbonylation by lipoxidation-derived reactive carbonyls. Med. Res. Rev. 27, 817\u2013868 (2007).","journal-title":"Med. Res. Rev."},{"key":"29_CR58","first-page":"388","volume":"11","author":"M Jov\u00e9","year":"2021","unstructured":"Jov\u00e9, M. et al. The Causal Role of Lipoxidative Damage in Mitochondrial Bioenergetic Dysfunction Linked to Alzheimer\u2019s Disease Pathology. Life Basel Switz. 11, 388 (2021).","journal-title":"Life Basel Switz."},{"key":"29_CR59","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3389\/fphys.2020.00598","volume":"11","author":"H Chew","year":"2020","unstructured":"Chew, H., Solomon, V. A. & Fonteh, A. N. Involvement of Lipids in Alzheimer\u2019s Disease Pathology and Potential Therapies. Front. Physiol. 11, 598 (2020).","journal-title":"Front. Physiol."},{"key":"29_CR60","volume":"10","author":"H Su","year":"2021","unstructured":"Su, H. et al. Characterization of brain-derived extracellular vesicle lipids in Alzheimer\u2019s disease. J. Extracell. Vesicles 10, e12089 (2021).","journal-title":"J. Extracell. Vesicles"},{"key":"29_CR61","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.addr.2020.04.011","volume":"159","author":"S Vanherle","year":"2020","unstructured":"Vanherle, S., Haidar, M., Irobi, J., Bogie, J. F. J. & Hendriks, J. J. A. Extracellular vesicle-associated lipids in central nervous system disorders. Adv. Drug Deliv. Rev. 159, 322\u2013331 (2020).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"29_CR62","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41565-020-0651-3","volume":"15","author":"G Fuhrmann","year":"2020","unstructured":"Fuhrmann, G. Diffusion and transport of extracellular vesicles. Nat. Nanotechnol. 15, 168\u2013169 (2020).","journal-title":"Nat. Nanotechnol."},{"key":"29_CR63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-022-04123-z","volume":"5","author":"C Zivko","year":"2022","unstructured":"Zivko, C., Fuhrmann, K., Fuhrmann, G. & Luciani, P. Tracking matricellular protein SPARC in extracellular vesicles as a non-destructive method to evaluate lipid-based antifibrotic treatments. Commun. Biol. 5, 1\u201313 (2022).","journal-title":"Commun. Biol."},{"key":"29_CR64","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejpb.2022.11.025","volume":"182","author":"C Zivko","year":"2023","unstructured":"Zivko, C., Witt, F., Koeberle, A., Fuhrmann, G. & Luciani, P. Formulating elafibranor and obeticholic acid with phospholipids decreases drug-induced association of SPARC to extracellular vesicles from LX-2 human hepatic stellate cells. Eur. J. Pharm. Biopharm. 182, 32\u201340 (2023).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"29_CR65","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3390\/cells8070727","volume":"8","author":"LM Doyle","year":"2019","unstructured":"Doyle, L. M. & Wang, M. Z. Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis. Cells 8, 727 (2019).","journal-title":"Cells"},{"key":"29_CR66","doi-asserted-by":"crossref","first-page":"9269","DOI":"10.1523\/JNEUROSCI.0147-18.2019","volume":"39","author":"AF Hill","year":"2019","unstructured":"Hill, A. F. Extracellular Vesicles and Neurodegenerative Diseases. J. Neurosci. Off. J. Soc. Neurosci. 39, 9269\u20139273 (2019).","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"29_CR67","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-3-030-32633-3_13","volume":"1195","author":"V Machairaki","year":"2020","unstructured":"Machairaki, V. Human Pluripotent Stem Cells as In Vitro Models of Neurodegenerative Diseases. Adv. Exp. Med. Biol. 1195, 93\u201394 (2020).","journal-title":"Adv. Exp. Med. Biol."},{"key":"29_CR68","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41380-019-0468-3","volume":"25","author":"J Penney","year":"2020","unstructured":"Penney, J., Ralvenius, W. T. & Tsai, L.-H. Modeling Alzheimer\u2019s disease with iPSC-derived brain cells. Mol. Psychiatry 25, 148\u2013167 (2020).","journal-title":"Mol. Psychiatry"},{"key":"29_CR69","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/978-3-030-78787-5_50","volume":"1339","author":"R Sagar","year":"2021","unstructured":"Sagar, R. et al. Biomarkers and Precision Medicine in Alzheimer\u2019s Disease. Adv. Exp. Med. Biol. 1339, 403\u2013408 (2021).","journal-title":"Adv. Exp. Med. Biol."},{"key":"29_CR70","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jalz.2011.05.2410","volume":"7","author":"CG Lyketsos","year":"2011","unstructured":"Lyketsos, C. G. et al. Neuropsychiatric symptoms in Alzheimer\u2019s disease. Alzheimers Dement. J. Alzheimers Assoc. 7, 532\u2013539 (2011).","journal-title":"Alzheimers Dement. J. Alzheimers Assoc."}],"container-title":["Advances in Experimental Medicine and Biology","GeNeDis 2022"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-31978-5_29","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T12:09:25Z","timestamp":1701086965000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-31978-5_29"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9783031319778","9783031319785"],"references-count":70,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-31978-5_29","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"1 August 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"GeNeDis","order":1,"name":"conference_acronym","label":"Conference Acronym","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Worldwide Congress on \u201cGenetics, Geriatrics and Neurodegenerative Diseases Research\"","order":2,"name":"conference_name","label":"Conference Name","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Zakinthos","order":3,"name":"conference_city","label":"Conference City","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Greece","order":4,"name":"conference_country","label":"Conference Country","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"2022","order":5,"name":"conference_year","label":"Conference Year","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"20 October 2022","order":7,"name":"conference_start_date","label":"Conference Start Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"22 October 2022","order":8,"name":"conference_end_date","label":"Conference End Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"genedis2022","order":10,"name":"conference_id","label":"Conference ID","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"https:\/\/www.genedis.eu\/","order":11,"name":"conference_url","label":"Conference URL","group":{"name":"ConferenceInfo","label":"Conference Information"}}]}}